DarioHealth Clinical Evidence in Diabetes

Last updated: Q3 2024

Clinical HbA1c study
  • Nita Thingalaya, David Kerr, et al. Impact of Digital Diabetes Solution on Glycemic Control in Adults with Type 2 Diabetes Mellitus in the United States—A Retrospective Cohort Study. Poster 962-P presented at ADA, Jun 2023. [abstract] [poster]
  • Nita Thingalaya, David Kerr, et al. Use of Digital Diabetes Solution Is Associated with Improved Glycemic Control without Increased Risk of Severe Hypoglycemia in Adults with Type 2 Diabetes Mellitus in the United States—Retrospective Cohort Study. Poster 139-LB presented at ADA, Jun 2023. [abstract] [poster]
  •  Nita Thingalaya, Daniel Malone, et al. The impact of a digital health technology on healthcare quality measures and clinical outcomes in adults with type 2 diabetes mellitus. Poster E9 presented at AMCP-Nexus, Oct 2023. [abstract]
  • Nita Thingalaya, Darren Frey, et al. Association between more frequent engagement with the Dario Diabetes Solution, a digital health technology, and a reduction in HbA1c in adults with type 2 diabetes mellitus. Poster E3 presented at AMCP-Nexus, Oct 2023. [abstract]
  • Nita Thingalaya, Darren Frey, et al. Impact of a Digital Diabetes Solution on Medication Adherence in Adults in the United States with Type 2 Diabetes Mellitus. Poster presented at Diabetes Technology Meeting, Nov 2023. [abstract will be published in JDST early 2024]
Health Economic HCRU Study
  • Laura Wilson, Daniel Malone, et al. Comparison of All-Cause Healthcare Utilization Rates Between Patients with Type 2 Diabetes Who Use a Digital Diabetes Solution Versus Non-Users: A 12-Month Retrospective Cohort Study. Poster presented at ISPOR, May 2023. [abstract] [poster]
  • Laura Wilson, Daniel Malone, et al. Effect of a Digital Diabetes Solution on All-Cause Health Care Resource Utilization Charges for Patients with Type 2 Diabetes—A Retrospective Cohort Study. Poster 126-LB presented at ADA, Jun 2023. [abstract] [poster]
  • Laura Wilson, Daniel Malone, et al. A retrospective cohort study comparing health care resource utilization, length of stay and 30-day readmissions in users and non-users of a digital diabetes health intervention for patients with type 2 diabetes mellitus. Poster E2 presented at AMCP-Nexus, Oct 2023. Gold medal poster award. [abstract]
  • Laura Wilson, Daniel Malone, et al. The Impact of Patient Engagement with a Digital Diabetes Solution on All-Cause Healthcare Resource Utilization Rates and Charges. Poster presented at ISPOR EU, Nov 2023. [abstract] [poster]
2023
  • Yifat Hershcovitz et al. Non-Linear Association Between Blood Glucose Levels and Walking in an Integrated Digital Health Platform for Diabetes Management. Poster presented at Diabetes Technology Meeting, Nov 2023. [abstract will be published in JDST early 2024]
  •  Inbar Breuer Asher, Emily Gibbons, Amir Gurewitz, Omar Manejwala and Yifat Fundiano-Hershcovitz. Users managing Diabetes with Large-scale Digital Therapeutics Platform Experience a Change in Blood Glucose and Engagement Over Two Years. Poster presented at ADCES, Aug 2023. [data on file – no abstract or poster in public domain]
  • Yifat Hershcovitz, Amir Gurewitz and Omar Manejwala. Impact of a Digital Health Educational Feature on Engagement and Glycemic Outcomes. Poster 146-LB presented at ADA, Jun 2023. [abstract] [poster]
  • Yifat Hershcovitz, Sofia Budman, Noga Yaniv and Omar Manejwala. Digital Platform Users Managing Three Chronic Conditions—Diabetes, Hypertension, and Overweight—Experience Better Outcomes than Those Who Manage One Condition Following Six Months. Poster 1069-P presented at ADA, Jun 2023. [abstract] [poster]
  • Yifat Hershcovitz, Noga Yaniv, Sofia Budman and Omar Manejwala. Blood Glucose Reduction and Long-Term Sustainability in High-Risk Patients with Type 2 Diabetes over Three Years of Using Digital Platform. Poster 1070-P presented at ADA, Jun 2023. [abstract] [poster]
  • Y. Fundoiano-Hershcovitz, S. Budman, N. Yaniv and O. Manejwala. Impact of Digital Coaching on Diabetes Self-Management and Glycemic Outcomes for People with Type 2 Diabetes. Poster OP064/#373 presented at ATTD, Feb 2023. [abstract]
  • Y. Fundoiano-Hershcovitz, S. Budman, N. Yaniv and O. Manejwala. Decrease in Hypoglycemia Events Over A Year in Older Adults with Diabetes Monitoring with Digital Diabetes Management System. Poster LB004/#1012 presented at ATTD, Feb 2023. [abstract]
  • Gershoni T, Ritholz MD, Horwitz DL, Manejwala O, Donaldson-Pitter T, Fundoiano-Hershcovitz Y. Glycemic Management by a Digital  Therapeutic Platform across Racial/Ethnic Groups: A Retrospective Cohort Study. Applied Sciences. 2023; 13(1):431. [article]
2022
  • Yifat Hershcovitz Ph.D, Tamar Gershoni, Roy Shimonovich, Emily Gibbons and Omar Manejwala M.D. Digital therapeutic platforms improve blood glucose management across rural/non-rural groups. Poster presented at ADCES, Aug 2022. [data on file – no abstract or poster in public domain]
  • Yifat Hershcovitz Ph.D, Tamar Gershoni and Omar Manejwala M.D. Blood Glucose Levels in High-Risk Type 2 Diabetes Users of a Digital Therapeutic Platform by Race/Ethnicity. Poster LB-72 presented at ADA 2022. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Michal Tamir and Omar Manejwala M.D. Hypertension Control among People with Diabetes Using a Self-Management Multicondition Digital Platform. Poster 708-P presented at ADA 2022. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Michal Tamir, Marilyn D. Ritholz and Omar Manejwala M.D. Persons with High-Risk Diabetes, Depression, and Stress Using a Digital Health Platform Experience an Improvement in Glycemic Management. Poster 709-P presented at ADA 2022. [abstract] [poster]
  • Yifat Hershcovitz Ph.D., Amit Lauterbach and Omar Manejwala M.D. Impact of a Digital Therapeutic Platform on Weight Loss and Diabetes Self-Management. Poster EP087/#334 presented at ATTD 2022. [abstract] [poster]
  • Fundoiano-Hershcovitz, Bacher D, Ritholz M, Horwitz D, Manejwala O, Goldstein P. Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study. J Med Internet Res 2022;24(2):e32923. [article]
2021
  • Yifat Hershcovitz Ph.D., Amit Lauterbach, Omar Manejwala M.D. and Dror Bacher. Efficacy of a tailored digital intervention tool targeting patients with clustered recurrent high glucose readings. Poster presented at ADCES 2021. [data on file – no abstract or poster in public domain]
  • Yifat Hershcovitz Ph.D, Sharon Dar, Omar Manejwala M.D. and Dror Bacher. Impact of Digital Intervention Tools on Engagement and Glycemic Outcomes. Poster 612-P presented at ADA 2021. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar, Omar Manejwala M.D. and Dror Bacher. Users with High-Risk Type 2 Diabetes Experience a Change in Blood Glucose Levels Using Digital Therapeutic Platform. Poster 611-P presented at ADA 2021. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Omar Manejwala M.D. Impact of a Digital Therapeutic on Insulin Self-Management. Poster P070/#221 presented at ATTD 2021. [abstract] [poster]
  • Yifat Hershcovitz Ph.D., Sharon Dar, Omar Manejwala M.D. and Dror Bacher. Impact of a Digital Intervention Engine on Diabetes Self Management. Poster #478 presented at ATTD 2021. [abstract] [poster]
  • Fundoiano-Hershcovitz Y, Feniger E, Dar S, Ritholz M, Schorr AB, Goldstein P. Digital Therapeutics for Type 2 Diabetes: Incorporating Coaching Support and Validating Digital Monitoring. Journal of Diabetes Science and Technology. 2021;15(5):1188-1189. [article]
  • Fundoiano-Hershcovitz Y, Hirsch A, Dar S, Feniger E, Goldstein P. Role of Digital Engagement in Diabetes Care Beyond Measurement: Retrospective Cohort Study. JMIR Diabetes 2021;6(1):e24030. [article]
2020
  • Yifat Hershcovitz Ph.D, Sharon Dar and Omar Manejwala M.D. The Effect of a Digital Therapeutic Platform on Glycemic Control in Adults above Age 65 with Type 2 Diabetes. Poster presented at Diabetes Technology Society Annual Meeting 2020. [poster] [case study]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Impact of Digital Management on Clinical outcome in Patients with Chronic Conditions: Diabetes and Hypertension. Poster presented at ADCES 2020. [data on file – no abstract or poster in public domain]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Estimated A1C reduction in high-risk patients over two years of using a digital diabetes management platform. Poster 859-P presented at ADA 2020. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Users with Type 2 Diabetes Using a Digital Platform Experienced Sustained Improvement in Blood Glucose Levels. Poster 860-P presented at ADA 2020. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Decrease in hypoglycemia events over two years in patients monitoring with a digital diabetes monitoring system. Poster 323/abstract ID 373 presented at ATTD 2020. [abstract] [poster]
2019
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. The effect of digital intervention on glycemic control in users with diabetes. Poster presented at DTS 2019. [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Impact of Digital Intervention on In-range Glucose Levels in Users with Diabetes. Poster presented at AADE 2019. [data on file – no abstract or poster in public domain]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Reduction of blood glucose average less than 140 mg/dl in people with type 2 diabetes using a digital diabetes management system. Poster 913-P presented at ADA 2019. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. T2D Users of a Digital Diabetes Management System Experience an Increase of In-Range Glucose Levels Linked to App Engagement. Poster 912-P presented at ADA 2019. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Decrease in glycemic variability for T2D over six months in patients monitoring with a digital diabetes management system. Poster 169 presented at ATTD 2019. [abstract] [poster]
2018
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Decrease in Estimated A1C for people in High-risk over a full year of users monitoring with a digital Diabetes management system. Poster presented at AADE 2018. [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Continuous Reduction of Blood Glucose Average during One Year of Glucose Monitoring Using a Digital Monitoring System in a High-Risk Population. Poster 78-LB presented at ADA 2018. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Decrease in High Readings and Severe Hyperglycemic Events for People with T2D over the Full Year of 2017 in Users Monitoring with a Digital Diabetes Management System. Poster 77-LB presented at ADA 2018. [abstract] [poster]
  • Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. T2D Users of a Digital Diabetes Management System Experience a Shift from Greater than 180 mg/dL to Normal Glucose Levels with Sustainable Results. Poster 76-LB presented at ADA 2018. [abstract] [poster] [white paper]
2017
  • Moshe Kamar MD, Yifat Hershcovitz Ph.D, Sharon Dar and Eitan Feniger. Reducing A1C Levels in Individuals with High-Risk Diabetes Using the Mobile Glucose Meter Technology. Poster 114-LB presented at ADA 2017. [abstract] [poster]

Dario Health’s website has a clinical research section that houses a selection of publications. Where possible, links on this page are to the original journal or conference source.